After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Most recently, Yahoo Finance reported about the stock as it publicized that Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, SMMT falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $4.53 and fluctuated between $4.6050 as its day high and $4.3100 as its day low. The current market capitalization of Summit Therapeutics Inc is $3.18B. A total of 1.14 million shares were traded on the day, compared to an average of 1.91M shares.
In the most recent transaction, Dhingra Ankur bought 20,400 shares of SMMT for 2.17 per share on Dec 13. After the transaction, the Chief Financial Officer now owns 254,958 company shares. In a previous transaction on Dec 12, Zanganeh Mahkam bought 5,000 shares at 2.07 per share. SMMT shares that Chief Executive Officer owns now total 494,814.
Among the insiders who bought shares, Soni Manmeet Singh acquired of 2,976,190 shares on Oct 13 at a per-share price of $1.68. This resulted in the Chief Operating Officer holding 2,976,190 shares of SMMT after the transaction. In another insider transaction, Zanganeh Mahkam bought 15,973,743 shares at $1.05 per share on Mar 08. Company shares held by the Co-Chief Executive Officer now total 23,395,269.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for SMMT in the last 3 months, the mean price target is $4.00 with high estimates of $4.00 and low estimates of $4.00. In terms of 52-week highs and lows, SMMT has a high of $5.14 and a low of $1.25.
As of this writing, SMMT has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SMMT’s latest balance sheet shows that the firm has $71.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.78M in debt and $25.62M in liabilities at the time. Its Book Value Per Share was $0.11, while its Total Shareholder’s Equity was $83.28M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SMMT is Buy with a score of 0.00.
